MarginsXMarginsX
Home › Markets › ZOMDF

Zomedica Corp. (ZOMDF)

ZOMDF is quoted over the counter, not listed on an exchange. Zomedica Corp. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0910
-7.1% on the day
1-year return
-5.2%
Market cap
$89.2M
Micro cap. From the Nov 16, 2026 close × 979.9M shares (10-Q cover page, Nov 4, 2026)
P/E and P/S
Net loss over the period · 2.3×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerZOMDF, quoted over the counter
SEC CIK0001684144
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressAnn Arbor, MI
Incorporated inAB

Warning signs

Cash runway
7.6 months
$7.3M cash at September 30, 2026
Share count, 1 year
0.0%
2025-11-03 to 2026-11-04 · 0.0% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
$190K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$7.3M cash; operating cash flow -$2.9M a quarter.Report 2026-09-30
Shares outstanding979,949,668 (2026-11-04); 979,949,668 a year earlier; 979,949,668 three years earlier.Cover page 2026-11-04
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-03-13
AuditorGrant Thornton LLP, Southfield, Michigan, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $190K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$9.9M-$3.2M-$2.8M$7.3MNo debt tags$38.7M10-Q 2026-11-04
Q2 2026
2026-06-30
$9.5M-$3.8M-$2.6M$7.2MNo debt tags$36.9M10-Q 2026-08-05
Q1 2026
2026-03-31
$8.8M-$4.5M-$5.3M$9.4MNo debt tags$34.3M10-Q 2026-05-06
Q4 2025
2025-12-31
$10.5M-$4.5M-$899K$9.0MNo debt tags$32.0M10-K 2026-03-16
Q3 2025
2025-09-30
$8.1M-$6.1M-$4.7M$7.5MNo debt tags$29.5M10-Q 2026-11-04
Q2 2025
2025-06-30
$7.0M-$7.4M-$5.4M$8.1MNo debt tags$28.4M10-Q 2026-08-05
Q1 2025
2025-03-31
$6.5M-$63.8M-$6.6M$8.8MNo debt tags$27.5M10-Q 2026-05-06
Q4 2024
2024-12-31
$7.9M-$7.2M-$4.5M$7.0MNo debt tags$27.3M10-K 2026-03-16

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52021-02-09
Latest annual report10-K2026-03-16
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEF 14A2026-04-27

Source: SEC EDGAR submissions feed, 483 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier